Overview
Osteomesopyknosis is an extremely rare inherited bone disorder characterized by abnormally increased bone density (osteosclerosis) that predominantly affects the axial skeleton, specifically the vertebral bodies and pelvis. Unlike many other sclerosing bone dysplasias, osteomesopyknosis typically spares the appendicular skeleton (limbs) and the skull. The condition was first described in the 1980s and derives its name from the Greek roots referring to bone (osteo), middle (meso), and dense (pyknos), reflecting the increased density seen primarily in the central or axial portions of the skeleton. The hallmark radiographic finding is a characteristic pattern of dense sclerosis of the vertebral bodies, particularly affecting the thoracic and lumbar spine, along with the pelvic bones. The sclerosis tends to involve the central portions of the vertebral bodies while relatively sparing the peripheral areas. Most affected individuals are identified incidentally on radiographs taken for other reasons, such as back pain, though the relationship between the skeletal findings and symptoms like back pain remains uncertain. Many patients may be asymptomatic, and the condition is generally considered benign. Osteomesopyknosis follows an autosomal dominant inheritance pattern, meaning that a single copy of the altered gene from one affected parent is sufficient to cause the condition. The specific genetic basis has not been fully elucidated. There is no specific treatment for osteomesopyknosis, as the condition is typically benign and does not lead to significant complications such as fractures, bone marrow failure, or cranial nerve compression, which can be seen in other sclerosing bone disorders. Management is generally supportive, with monitoring and symptomatic treatment of any associated back pain if present.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Osteomesopyknosis.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Osteomesopyknosis at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Osteomesopyknosis.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Osteomesopyknosis.
Community
No community posts yet. Be the first to share your experience with Osteomesopyknosis.
Start the conversation →Latest news about Osteomesopyknosis
No recent news articles for Osteomesopyknosis.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Osteomesopyknosis
What is Osteomesopyknosis?
Osteomesopyknosis is an extremely rare inherited bone disorder characterized by abnormally increased bone density (osteosclerosis) that predominantly affects the axial skeleton, specifically the vertebral bodies and pelvis. Unlike many other sclerosing bone dysplasias, osteomesopyknosis typically spares the appendicular skeleton (limbs) and the skull. The condition was first described in the 1980s and derives its name from the Greek roots referring to bone (osteo), middle (meso), and dense (pyknos), reflecting the increased density seen primarily in the central or axial portions of the skeleto
How is Osteomesopyknosis inherited?
Osteomesopyknosis follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.